M&T Bank Corp Ginkgo Bioworks Holdings, Inc. Transaction History

M&T Bank Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$0.28 - $1.16 $3,590 - $14,873	-12,822 Reduced 26.31%	35,921 $11,000
Q1 2024 May 07, 2024	BUY	$1.06 - $1.67 $4,035 - $6,357	3,807 Added 8.47%	48,743 $56,000
Q4 2023 Feb 06, 2024	BUY	$1.26 - $1.79 $1,132 - $1,609	899 Added 2.04%	44,936 $75,000
Q3 2023 Nov 02, 2023	BUY	$1.61 - $2.54 $8,763 - $13,825	5,443 Added 14.1%	44,037 $79,000
Q2 2023 Aug 09, 2023	BUY	$1.14 - $1.95 $7,705 - $13,180	6,759 Added 21.23%	38,594 $71,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $7,430 - $13,560	-6,192 Reduced 16.28%	31,835 $42,000
Q4 2022 Feb 13, 2023	SELL	$1.63 - $3.52 $130,266 - $281,311	-79,918 Reduced 67.76%	38,027 $64,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $137,096 - $296,060	84,108 Added 248.57%	117,945 $199,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $2,438 - $12,495	3,341 Added 10.96%	33,837 $101,000
Q2 2022 Aug 05, 2022	BUY	$2.2 - $4.2 $67,091 - $128,083	30,496 New	30,496 $72,000

49.2M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $8.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.